This article comes from micro-channel public number: China News Weekly (ID: chinanewsweekly) , author: Peng Danni, the original title: “Chinese medicine injections into the new crown
“We are not excluding the participation of Chinese medicine, but it should not be placed in a prominent position.”
《New Coronary Virus Infected Pneumonia Diagnosis and Treatment Program (Trial) “has been updated several times. The latest version is released on January 27. The fourth edition is jointly issued by the General Office of the National Health Commission and the Office of the State Administration of Traditional Chinese Medicine.
It is worth noting that The “Diagnosis and Treatment Program” introduces TCM treatment in the treatment section. This section will stage the disease into “early, intermediate, severe and recovery phases” in turn, and recommend the corresponding prescription or proprietary Chinese medicine.
Taking “medium term: epidemic poisoning and closing the lungs” as an example, the traditional Chinese medicine recommended in the “Diagnosis and Treatment Plan” is Xiyanping injection and Xuebijing injection. However, Li Zhiling, Department of Pharmacy, Shanghai Children’s Hospital, previously said in an interview with the media that Xi Yanping’s efficacy is not clear, its safety is not certified, and it is not recommended.
Chen Feng is a well-known child ICU director in China. He has just written the guidelines for the diagnosis and treatment of neonatal coronavirus pneumonia infection in his hospital, which includes antiviral, antibacterial, immunomodulatory, and respiratory support treatments. There is no mention of proprietary Chinese medicines. He told us that he would not use proprietary Chinese medicines including Xiyanping injection in the clinic. “I believe that the answer of every evidence-based doctor is the same.”
A doctor at Peking Union Medical College Hospital also said that In this type of diagnosis and treatment plan, the “Chinese medicine treatment” part will appear regularly.
The composition of Xiyanping injection is andrographolide sulfonate. The indications approved by the Food and Drug Administration are “clearing heat and detoxifying, cough and dysentery”, and it is used for a variety of diseases such as bronchitis, tonsillitis, and bacterial dysentery. The drug has been on the market for more than 30 years. In 2016, Xiyanping injection ranked among the top three in the market for Qingrejiedu Chinese medicine injections, with a market size of about 2.6 billion yuan that year, which is often used in pediatrics.
According to the data of the spontaneous reporting system of the National Center for Adverse Drug Reaction Monitoring, there were 9,633 cases of Xiyanping adverse reactions reported between 2005 and 2012. In September 2017, the notice issued by the State Food and Drug Administration (CFDA) states that the National Adverse Drug Reaction Monitoring Center found that a pharmaceutical company in Jiangxi Xiyanping injection of Gansu, Heilongjiang and Jiangsu had more than ten cases of Severe adverse reactions such as chills and fever .
In response, the CFDA requires Xiyanping injection manufacturers to immediately recall the product, order it to stop selling the product, and thoroughly investigate the cause of the quality problem of the drug, and do not resume sales until the cause is identified and rectified. On November 30 of that year, Xiyanping Injection was ordered to stop production for more than two months for inspection, and the production was resumed with the consent of the Food and Drug Administration of Jiangxi Province.
According to public reports in the media, this injection has been fatal. The Health Times reported that in December 2017, a 10-year-old child in Shaanxi suddenly developed symptoms of shock during the infusion process and died after being ineffective after rescue. He was injected with a 5% glucose injection mixture before the death. Yanping injection.
Miao Xiaohui is a clinical consultant for public health in Shanghai. He participated in the SARS prevention and control of Shanghai and Beijing Xiaotangshan in 2003. He said in an interview with “China News Weekly” that the formulation of the “Diagnosis and Treatment Plan” should be led by the National Health Commission and coordinated by the National Center for Disease Control and Prevention. The main topics of specialized committees such as the Infectious Diseases Branch and Epidemiology Branch of the Chinese Medical Association Experts are involved.
Miao Xiaohui said that the introduction of a diagnosis and treatment plan is necessary, but it requires professionals and multiple check-up procedures to ensure its authority and seriousness. For emerging infectious diseases, If it involves Chinese medicine treatment, it depends on its modern Whether evidence-based medicine can withstand the test of evidence.
Zhang Boli, President of Tianjin University of Traditional Chinese MedicineIn an interview with Xinhua News Agency on January 27, it was stated that “Chinese medicine has curative effects in reducing fever symptoms, controlling disease progression, reducing hormone consumption, and reducing complications.” It does not exclude the participation of Chinese medicine, but it should not be placed in a prominent position. “
This article comes from micro-channel public number: China News Weekly (ID: chinanewsweekly) , author: Peng Danni